Xencor Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Great. Thank you so much. Good afternoon and good morning depending on where you are in the world. Welcome to Barclays Global Healthcare Conference. My name is Peter Lawson. I'm one of the biotech equity analysts at Barclays. I just want to thank everybody for taking time out of the day today. If you've got questions, do ping me at [email protected] or get me on Bloomberg.
It gives me great pleasure to introduce the management team from Xencor. And we have Bassil Dahiyat with us, CEO. We've also got Charles from IR with us as well.
Questions & Answers
And just to start the ball rolling with questions. I've been asking most of my companies this, just the -- where you view Xencor's kind of point of differentiation in the oncology space and kind of the core competencies of the company?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |